Assignee
SORRENTO THERAPEUTICS INC
US·108 granted patents·70 pending applications·255 citations·filing 2012–2024
Top patents by PatentIndex Score
178 records- 0197US10058609B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Aug 28, 2018·17 cites·14 claims
- 0295US12084503B2Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatmentSORRENTO THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·2 cites·18 claims
- 0394US10213588B2Transdermal delivery of high viscosity bioactive agentsSORRENTO THERAPEUTICS INC·Filed 2017·Granted Feb 26, 2019·5 cites·37 claims
- 0494US10118963B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Nov 6, 2018·12 cites·17 claims
- 0594US10100118B2Antibody therapeutics that bind CD123SORRENTO THERAPEUTICS INC·Filed 2016·Granted Oct 16, 2018·6 cites·32 claims
- 0692US11247033B2Transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2019·Granted Feb 15, 2022·10 cites·18 claims
- 0792US10940085B2Cartridge portion of transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2018·Granted Mar 9, 2021·10 cites·14 claims
- 0892US10800852B2Antibody therapeutics that bind CD38SORRENTO THERAPEUTICS INC·Filed 2018·Granted Oct 13, 2020·3 cites·20 claims
- 0992US9676853B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2014·Granted Jun 13, 2017·15 cites·20 claims
- 1091US10590165B2Antibody drug conjugatesSORRENTO THERAPEUTICS INC·Filed 2016·Granted Mar 17, 2020·7 cites·14 claims
- 1191US10377827B2Antigen binding proteins that bind c-metSORRENTO THERAPEUTICS INC·Filed 2013·Granted Aug 13, 2019·14 cites·6 claims
- 1291US10233251B2Antibody therapeutics that bind CD137SORRENTO THERAPEUTICS INC·Filed 2016·Granted Mar 19, 2019·7 cites·19 claims
- 1391US10232160B2Transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2015·Granted Mar 19, 2019·10 cites·30 claims
- 1491US10111807B2Cartridge portion of transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2015·Granted Oct 30, 2018·10 cites·28 claims
- 1590US10953211B2Transdermal drug delivery deviceSORRENTO THERAPEUTICS INC·Filed 2018·Granted Mar 23, 2021·10 cites·18 claims
- 1690US10059774B2Antibody therapeutics that bind CD38SORRENTO THERAPEUTICS INC·Filed 2016·Granted Aug 28, 2018·6 cites·22 claims
- 1789US11142579B2Variant antibodies that bind OX40SORRENTO THERAPEUTICS INC·Filed 2018·Granted Oct 12, 2021·3 cites·19 claims
- 1889US11040183B2Receptacle portion of transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2015·Granted Jun 22, 2021·10 cites·24 claims
- 1989US10328248B2Controller portion of transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2015·Granted Jun 25, 2019·10 cites·23 claims
- 2089US10035855B2Antibody therapeutics that bind CD47SORRENTO THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·8 cites·15 claims
- 2188US10919964B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2018·Granted Feb 16, 2021·2 cites·16 claims
- 2287US11180568B2Antibody therapeutics that bind CD137SORRENTO THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·3 cites·19 claims
- 2387US10934361B2Antibody therapeutics that bind CD123SORRENTO THERAPEUTICS INC·Filed 2018·Granted Mar 2, 2021·2 cites·14 claims
- 2487US10806914B2Composite microneedle array including nanostructures thereonSORRENTO THERAPEUTICS INC·Filed 2018·Granted Oct 20, 2020·3 cites·14 claims
- 2587US10301395B2Chemically-locked bispecific antibodiesSORRENTO THERAPEUTICS INC·Filed 2016·Granted May 28, 2019·3 cites·14 claims
- 2686US9902772B2Antibody therapeutics that bind LAG3SORRENTO THERAPEUTICS INC·Filed 2016·Granted Feb 27, 2018·5 cites·10 claims
- 2785US11135414B2Medical devices for delivery of siRNASORRENTO THERAPEUTICS INC·Filed 2018·Granted Oct 5, 2021·1 cites·18 claims
- 2884US11179555B2Nanopatterned medical device with enhanced cellular interactionSORRENTO THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·2 cites·20 claims
- 2984US11174314B2Anti-KRAS binding proteinsSORRENTO THERAPEUTICS INC·Filed 2019·Granted Nov 16, 2021·2 cites·20 claims
- 3084US10737082B2Methods for lymphatic delivery of active agentsSORRENTO THERAPEUTICS INC·Filed 2016·Granted Aug 11, 2020·4 cites·9 claims
- 3182US11129975B2Transdermal delivery of high viscosity bioactive agentsSORRENTO THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·2 cites·10 claims
- 3282US10709884B2Device for delivery of rheumatoid arthritis medicationSORRENTO THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·2 cites·14 claims
- 3382US10519245B2Antibodies which bind insulin-like growth factor receptor-1 (IGF1R) and methods of use thereof to treat cancerSORRENTO THERAPEUTICS INC·Filed 2013·Granted Dec 31, 2019·6 cites·12 claims
- 3482US9951144B2Antibody therapeutics that bind CD38SORRENTO THERAPEUTICS INC·Filed 2016·Granted Apr 24, 2018·2 cites·4 claims
- 3581US12017031B2Nanopatterned medical device with enhanced cellular interactionSORRENTO THERAPEUTICS INC·Filed 2021·Granted Jun 25, 2024·0 cites·20 claims
- 3679US11760806B2CD-38 directed chimeric antigen receptor constructsSORRENTO THERAPEUTICS INC·Filed 2018·Granted Sep 19, 2023·2 cites·18 claims
- 3779US11155623B2Antibody therapeutics that bind CTLA4SORRENTO THERAPEUTICS INC·Filed 2019·Granted Oct 26, 2021·1 cites·8 claims
- 3879US10342965B2Method for increasing the permeability of an epithelial barrierSORRENTO THERAPEUTICS INC·Filed 2017·Granted Jul 9, 2019·2 cites·24 claims
- 3979US9315579B2Antigen binding proteins that bind CCR2SORRENTO THERAPEUTICS INC·Filed 2013·Granted Apr 19, 2016·3 cites·8 claims
- 4079US2024238570A1Methods for better delivery of active agents to tumorsSORRENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4179US2024181235A1Methods for lymphatic delivery of active agentsSORRENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4278US10806913B2Methods for better delivery of active agents to tumorsSORRENTO THERAPEUTICS INC·Filed 2016·Granted Oct 20, 2020·2 cites·14 claims
- 4378US10435476B2Antibody therapeutics that bind JAG1SORRENTO THERAPEUTICS INC·Filed 2016·Granted Oct 8, 2019·4 cites·5 claims
- 4478US2023137871A1Device for delivery of rheumatoid arthritis medicationSORRENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4577US11878058B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·0 cites·19 claims
- 4677US11013816B2Antibody drug conjugates having derivatives of amatoxin as the drugSORRENTO THERAPEUTICS INC·Filed 2017·Granted May 25, 2021·1 cites·17 claims
- 4777US10584168B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Mar 10, 2020·1 cites·7 claims
- 4875US11746156B2Antibody therapeutics that bind CD123SORRENTO THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·0 cites·14 claims
- 4975US11235101B2Fluid delivery apparatus having a gas extraction device and method of useSORRENTO THERAPEUTICS INC·Filed 2020·Granted Feb 1, 2022·0 cites·20 claims
- 5075US10202453B2Antibody therapeutics that bind CTLA4SORRENTO THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·1 cites·15 claims
Showing the top 50 of 178 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SORRENTO THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →